How did GMAB's Q3 2023 earnings surprise impact its stock?

Genmab's (GMAB) Q3 2023 earnings report showed a significant positive surprise, with a net income growth of 181.97% and a net income of $533.69 million. Despite this positive news, the stock experienced a decline of 4.42%. This suggests that the market may have had concerns or reacted differently to the earnings report, which is worth investigating further for a comprehensive understanding.

|code|Ticker|Name|Date|Percentage Change|Percentage Change YoY|market_code|
|---|---|---|---|---|---|---|
|GMAB|GMAB.O|Genmab|20230103|1.5337||185|
|GMAB|GMAB.O|Genmab|20230104|-1.2085||185|
|GMAB|GMAB.O|Genmab|20230105|-0.9174|68.95326406985008|185|
|GMAB|GMAB.O|Genmab|20230106|1.8281||185|
|GMAB|GMAB.O|Genmab|20230109|-0.2798|-407.8039927404718|185|
|GMAB|GMAB.O|Genmab|20230110|1.0521||185|
|GMAB|GMAB.O|Genmab|20230111|-6.733||185|
|GMAB|GMAB.O|Genmab|20230112|-0.769||185|
|GMAB|GMAB.O|Genmab|20230113|0.4||185|
|GMAB|GMAB.O|Genmab|20230117|-0.3984||185|